legislation: 109-s-3582
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| bill_id | congress | bill_type | bill_number | title | policy_area | introduced_date | latest_action_date | latest_action_text | origin_chamber | sponsor_name | sponsor_state | sponsor_party | sponsor_bioguide_id | cosponsor_count | summary_text | update_date | url |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 109-s-3582 | 109 | s | 3582 | Preserve Access to Affordable Generics Act | Commerce | 2006-06-27 | 2006-06-27 | Read twice and referred to the Committee on Commerce, Science, and Transportation. (text of measure as introduced in Senate: CR S6578) | Senate | Sen. Kohl, Herb [D-WI] | WI | D | K000305 | 5 | Preserve Access to Affordable Generics Act - Amends the Federal Trade Commission Act to deem it to be an unfair method of competition affecting commerce for a person, in connection with the sale of a drug product, to be a party to any agreement resolving or settling a patent infringement claim in which: (1) an abbreviated new drug (generic) application filer receives anything of value; and (2) such filer agrees not to research, develop, manufacture, market, or sell the generic product for any period. Excludes a resolution or settlement that includes no more than the right to market the generic product prior to the expiration of the patent. | 2023-01-13T04:50:37Z |